Schering talks with cancer diagnostics company
This article was originally published in Clinica
Biomoda, a privately-owned US company with a worldwide licence for a test for the very early detection of lung cancer, has announced that has it has been approached by a subsidiary of Schering and preliminary discussions have taken place between the companies.
You may also be interested in...
The Mallorca-based biotech is building a strong data package for SNF472 which the company believes will be an effective treatment for a number of calcification disorders in dialysis patients.
India’s Sun Pharma has been denied leave to appeal against a US court decision rejecting the company’s bid for dismissal of a multi-district antitrust lawsuit.
Former Sandoz executive Hector Armando Kellum has admitted involvement in a US generic price-fixing conspiracy, the US Department of Justice has announced.